Skip to main content
Log in

Radioreceptor Assay of Metoprolol in Human Plasma: Comparison with an Enantiospecific High-Performance Liquid Chromatographic (HPLC) Procedure

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Plasma concentrations of metoprolol after acute and repetitive administration of R/S-metoprolol to healthy volunteers were measured by a β-adrenoceptor subtype-specific radioreceptor assay (RRA) and by an enantiospecific high-performance liquid chromatographic (HPLC) method. In the RRA, R/S-metoprolol showed a 20-fold β1-subtype selectivity: the S-( – )-enantiomer was 35-fold more potent than the R-( + )-enantiomer. A comparison between S-( – )-metoprolol concentrations detected in the plasma samples by HPLC and those detected by RRA yielded a 1/1 relationship, indicating that active metabolites are not present to a significant extent. These results were independent of the widely scattering metabolic clearance of metoprolol (with the potential of differences in the rate and extent of formation of active metabolites) in the volunteers. In general, HPLC methods can be validated by comparison with RRA in order to clarify whether active metabolites are present and—on the basis of the Ki value from RRA—whether the detection limit of the physicochemical procedure is sufficient to cover the therapeutically relevant range.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. H. Druckrey and K. Küpfmüller. Pharmazie 8 (Suppl. 1):514–645 (1949).

    Google Scholar 

  2. A. Wellstein, D. Palm, G. G. Belz, and H. F. Pitschner. Drug Res. 35:2–6 (1985).

    Google Scholar 

  3. A. Wellstein and D. Palm. Eur. J. Clin. Pharmacol. 29:293–300 (1985).

    Google Scholar 

  4. B. Testa. Trends Pharmacol. Sci. 7:60–64 (1986).

    Google Scholar 

  5. E. J. Arïens. Eur. J. Clin. Pharmacol. 26:663–668 (1984).

    Google Scholar 

  6. J. C. McGourty, J. H. Silas, M. S. Lennard, G. T. Tucker, and H. F. Woods. Br. J. Clin. Pharm. 20:555–566 (1985).

    Google Scholar 

  7. M. S. Lennard, G. T. Tucker, J. H. Silas, S. Freestone, L. E. Ramsey, and H. F. Woods. Clin. Pharmacol. Ther. 34:732–737 (1983).

    Google Scholar 

  8. G. Pflugmann, W. Kirch, E. E. Ohnhaus, H. Spahn, E. Mutschler, and M. Eichelbaum. Submitted for publication.

  9. W. Kirch, E. E. Ohnhaus, C. Zekorn, M. Eichelbaum, H. Spahn, and E. Mutschler. Arch. Pharmacol. Suppl. 8:401–402 (1985).

    Google Scholar 

  10. A. Wellstein, D. Palm, J. H. Matthews, and G. G. Belz. Meth. Find. Exp. Clin. Pharmacol. 7:645–651 (1985).

    Google Scholar 

  11. A. Wellstein, D. Palm, G. Wiemer, M. Schäfer-Korting, and E. Mutschler. Eur. J. Clin. Pharmacol. 27:545–553 (1985).

    Google Scholar 

  12. G. Pflugmann, H. Spahn, and E. Mutschler. J. Chromatogr. 421:161–164 (1987).

    Google Scholar 

  13. A. Wellstein, D. Palm, G. G. Belz, and H. F. Pitschner. Eur. J. Clin. Pharmacol. 29:131–147 (1985).

    Google Scholar 

  14. J. H. Silas, J. C. McGourty, M. S. Lennard, G. T. Tucker, and H. F. Woods. Eur. J. Clin. Pharmacol. 28:85–88 (1985).

    Google Scholar 

  15. A. Wellstein, D. Palm, G. G. Belz, G. Leopold, K. V. Bühring, and J. Pabst. J. Cardiovasc. Pharmacol. 8 (Suppl. 11):S41–S45 (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spahn, H., Wellstein, A., Pflugmann, G. et al. Radioreceptor Assay of Metoprolol in Human Plasma: Comparison with an Enantiospecific High-Performance Liquid Chromatographic (HPLC) Procedure. Pharm Res 6, 152–155 (1989). https://doi.org/10.1023/A:1015984626848

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015984626848

Navigation